Contact us

including iternational prefix number

Conference - Presentations

Transnational reproductive Biology and Clinical Reproductive Endocrinology

6-19/11/17, New York, USA

Following a highly successful 2016 Conference, which got glowing evaluations from registrants from 51 countries, the 2017 Conferences promises to be even bigger and better. It again offers a unique opportunity to visit New York City in the very popular pre-Christmas season at greatly discounted hotel costs, and the Organizing Committee again guarantees that the program, except for 6 Pre-Conference Workshops all held in a single auditorium, will really induce a new mindset of  “thinking differently” that will change clinical practice patterns and induce new research concepts. For those who cannot attend the Annual ASRM Meeting in San Antonio, Texas, the Conference for the first time will offer a session on the ASRM’s “most interesting presentations.”

The Conference is sponsored and organized by the Foundation for Reproductive Medicine (FRM), a not-for-profit research foundation exclusively dedicated to research in reproductive medicine and biology.

We are looking forward to welcoming you in New York City!

David F. Albertini | Norbert Gleicher | Zeev Shoham
Co-Chairpersons

 

 

 

 

BIT's International Congress of Gynaecology and Obstetrics China

01-03/11/17, Taiyuan, China

CGO China-2017 provides a unique and ideal opportunity for a broad spectrum of researchers, clinicians and other health professionals to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of gynaecology and obstetrics in the world. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries into better diagnosis and treatment of gynaecology and obstetrics patients.
ICGO China-2017 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the in-depth findings into the cause and processes of the disease and recent advances in clinical practice, from prevention to diagnosis, treatment and care.

 

 

 

 

The new POSEIDON criteria

13-14/10/17, Athens, Greece

Managing patients with impaired or poor ovarian response (POR) is a challenging issue. Number of oocytes retrieved has been adopted as a criterion of POR in most clinical trials, although the threshold number differs considerably between studies. A panel of experts (Patient-Oriented Strategies Encompassing Individualized Oocyte Number, the POSEIDON group) recently proposed new criteria to help guide the physician in handling POR patients.
This workshop will introduce the new POSEIDON criteria as a means to improve the management of patients exposed to assisted reproductive technologies, promote more specific approaches to patients with impaired prognosis during IVF, thereby offering better tools with which to optimize IVF success rates.

 

 

 

 

International Society of in Vitro Fertilazation, 19th World Congress

04-08/10/17, Antalya, Turkey

Reproductive Medicine Assisted Reproductive Technologies, Reproductive Genetics and Surgery are witnessing a significant expansion both clinically and in basic research. Obviously they will continue to undergo innovative and revolutionary changes in the forthcoming years, which may change our understanding and practice in the diagnosis and treatment of infertile couples. The information which will be accumulated in the near future especially in the field of stem cell research, molecular reproduction and human genetics may help our profession to be able to help more couples to have healthy babies.

Both Societies; International Society of Infertility and In Vitro Fertilization (ISIVF) and Society of Reproductive Medicine and Surgery (SRMS) are dedicated to the diagnosis and treatment of infertility and reproductive health including the promotion of science and research in all aspects of reproductive medicine and assisted reproductive technologies and human genetics, the understanding of evidence-based practices between clinicians and the enhancement of communication between scientists interested in these subjects worldwide.

 

 

 

 

Middle East Fertility Society, 24th Annual Meeting

28-30/09/17, Dubai, United Arab Emirates

http://www.mefs.org/scientific.htm

Dear colleagues

On behalf of the executive committee, we are greatly honored and pleased to welcome you to attend the 24th Annual Meeting of the Middle East Fertility Society (MEFS) that will be held from September 28-30, 2017 in Grand Hyatt Dubai, UAE.

This year’s conference promises to be an exciting and rewarding one. A panel of highly distinguished international and local faculty speakers will offer the latest updates on the fields of human reproduction, fertility and infertility treatment, in addition to the high-standard presentations and lectures.

The MEFS annual meeting has traditionally become the meeting point where all fertility specialists across the Middle East find the opportunity to exchange scientific information, renew social bonds, strengthen national solidarity, and consolidate cultural heritage.

The host city, Dubai, is one of the most attractive touristic cities in the world, offering numerous attractions. You need not to be a professional diver to enjoy the city. there is an abundance of history to explore, a traditional cuisine to enjoy, an eyeful of breathtaking architecture here, and a good-natured haggle over a carpet there.

We offer you our warmest welcome and we look forward to count you among the conference participants, and I encourage you to register as soon as possible and make plans to join your colleagues and friends in Dubai to make the meeting a wonderful and memorable event.

Prof Marwan Alhalabi, MD PhD

President of the Middle East Fertility Society